Abstract:Background: Hyperlipidemia {hypercholesterolemia [cholesterol >5.18 mmol/L) or hypertriglyceridemia [triglycerides >2.3 mmol/L], mixed hyperlipidemia [cholesterol >5.18 mmol/L and triglycerides >2.3 mmol/L], and high low-density lipoproteinemia [low-density lipoprotein (LDL) >3.4 mmol/L]} is a strong risk factor for arteriosclerosis and cardiovascular disease (CVD). Therapy with lipid-lowering drugs often results in many side effects. Our study aimed to investigate the potential effects of non-drug therapy with double-filtration plasmapheresis (DFPP) on lipid metabolism-, endoplasmic reticulum (ER) stress-, and apoptosis-related proteins in peripheral blood mononuclear cells (PBMCs) before and after lipid clearance in patients with hyperlipidemia. Methods: Thirty-five hyperlipidemia patients were selected. Proteins related to lipid metabolism [CD36, proprotein convertase subtilisin/kexin type 9 (PCSK9), and LDL receptor], ER stress [glucose-regulated protein 78 (Grp78), C/EBP homologous protein (CHOP), activating transcription factor 4 (ATF4), and eukaryotic initiation factor 2α (EIF2α)], and apoptosis [B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (BAX), and cysteinyl aspartate specific proteinase-3 (Caspase-3)] were assayed by Western blot, reactive oxygen species (ROS) were measured by flow cytometry (FCM), and ELISA detected serum inflammatory [interleukin (IL)-1β, IL-6, and tumor necrosis factor α (TNF-α)] factors. Results: Compared with their pre-DFPP values, the values of most lipid metabolic parameters, such as cholesterol, triglycerides, LDL, lipoprotein a [Lp(a)], and small dense LDL (sdLDL) cholesterol, were reduced after DFPP. DFPP was associated with the downregulation of proteins related to lipid metabolism, ER stress, and apoptosis, resulting in decreased ROS and serum inflammatory factor release. Conclusion: DFPP has lipid-lowering activity and can also regulate lipid metabolism-, ER stress-, and apoptosis-related proteins in PBMCs and reduce the levels of inflammatory factors in patients with hyperlipidemia ( ClinicalTrials.gov number: NCT03491956).

Double filtration plasmapheresis for treatment of hyperlipodemia and acute hyperlipodimic pancreatitis

[Double Filtration Plasmapheresis in Treatment of Hyperlipidemic Acute Pancreatitis].

Efficacy of Xuan Bai Cheng Qi Tang and mirabilite combined with pulse high-volume hemofiltration for treatment of patients with severe acute pancreatitis

A single-center experience of non-bioartificial DFAPP support systems among Chinese patients with hyperlipidemic moderate/severe acute pancreatitis

Efficiency of Double Plasma Molecular Absorption System on the Acute Severe Cholestatic Hepatitis.

Treatment of Refractory Hyperlipidemia Using Double Filtration Plasmapheresis System(DFPP)

Application of Lipid Apheresis in Acute Lipogenic Pancreatitis

Plasma Purification Treatment Relieves the Damage of Hyperlipidemia to PBMCs

Effect of plasmapheresis versus standard treatment in preventing recurrent acute pancreatitis in Chinese patients with hypertriglyceridemia

Clinical effects of double filtration plasmapheresis for sensitized recipients of cadaver kidney transplantation

Impact of therapeutic plasmapheresis on the duration of organ failure in patients with hypertriglyceridemia-associated acute pancreatitis

Early Plasmapheresis Among Patients With Hypertriglyceridemia–Associated Acute Pancreatitis

Plasmapheresis compared with conventional treatment for hypertriglyceridemia‐induced acute pancreatitis: A systematic review and meta‐analysis

[Clinical Research of Plasma Exchange with Continuous Veno-Venous Hemofiltration in Treating Mid- and Late-Stage Chronic Severe Viral Hepatitis B Patients].

Treatment of rejection and highly sensitized in kidney transplantation with double filtration plasmapheresis

Adjunctive Continuous High-Volume Hemofiltration in Patients with Acute Severe Pancreatitis: a Prospective Nonrandomized Study.

Adjunctive Continuous High-Volume Hemofiltration in Acute Severe Pancreatitis Patients: A Retrospective Study

Effects of Plasma Exchange Combined with Continuous Renal Replacement Therapy on Acute Fatty Liver of Pregnancy.

A Clinical Study on the Treatment of Severe Hepatitis by a Combined Artificial Liver.

Clinical Features of Acute Hyperlipidemic Pancreatitis

The Clinical Efficacy of Double Plasma Molecular Absorption System Combined with Plasma Exchange in the Treatment of Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis